美股A股
StockGist
Back
20-F2026-05-15· grok-4-1-fast-non-reasoning

AIXI · Xiao-I Corporation

0001213900-26-057986

SEC filing

Summary

FY2025 delivered catastrophic results with revenue plunging 82.5% to $12.3M amid strategic realignment, while restructuring costs escalated operating losses to -$96.6M and net loss to -$101.2M, highlighting execution challenges and liquidity pressures.

Key takeaways

Full analysis

Xiao-I Corporation's FY2025 results reflect a year of aggressive strategic realignment, slashing revenue 82.5% to $12.3M from $70.3M while gross profit declined 88.6% to $5.5M. This revenue contraction stems from portfolio cleanup, discontinuing lower-margin activities to prioritize core AI capabilities, enabling gross margin expansion to 44.4%—a testament to improved product mix efficiency despite top-line pressure.

Operating performance deteriorated sharply, with operating income plunging to -$96.6M (-650.5% YoY) and net income to -$101.2M (-597.8% YoY), diluted EPS at -$2.44. These losses arise from heightened operating expenses during restructuring, as management executed cost realignment and operational efficiency measures. The company notes efforts to reduce costs and expenses, yet the scale of one-time charges overwhelmed revenue, signaling the transitional pain of repositioning for sustainable growth.

Balance sheet strains are evident in rising accounts payable from business growth and extended supplier terms, alongside increased accrued expenses from payroll and taxes—common in scaling operations. Prepaid expenses rose due to marketing promotions and third-party receivables, indicating investment in growth initiatives. PRC restrictions limit withdrawals of registered capital and reserves up to net assets in subsidiaries, constraining dividend flows, consistent with plans to retain earnings for business expansion rather than payouts.

Looking ahead, management expects costs to rise with operational expansion and R&D investments, placing demands on resources. Scaling AI and potential hardware operations introduces risks in supply chain management, quality control, cost containment, production capacity, and support—critical as Xiao-I commercializes core technologies. This realignment positions the company for a higher-margin AI-focused trajectory, but success hinges on execution: stabilizing revenue, monetizing innovations, managing cash burn, and navigating regulatory constraints while maintaining Nasdaq compliance.